EPHA2 and breast neoplasm: Together, these data suggest that elevated EphA2 expression in breast tumor cells promotes osteolytic disease in bone metastasis, at least in part, by upregulating IL‐6, which in turn enhances osteoclast differentiation to facilitate osteolysis.